The world's first TIL therapy is approved for marketing

Ginkgo: Total revenue in 2023 will be US$251 million, a decrease of 47%.The bio-pharmaceutical field will be the largest market in the future

US health insurance “cannot afford” $3 million in gene therapy

Gene therapy drugs

CBT-004, a new drug for the treatment of congestive macula, completed Phase II clinical trial in the US and the first patient was enrolled